22 May 2013
Keywords: hollis, eden, presents, preclinical, data, cf, drug
Article | 26 June 2006
San Diego, USA-based Hollis-Eden Pharmaceuticals says that its scientists have presented data detailing the oral activity of five
candidate compounds ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 June 2006
21 May 2013
© 2013 thepharmaletter.com